Search Tag: urinary tract infections
2023 10 Nov
Antibiotic-resistant urinary tract infections (UTIs) are becoming an increasingly common and concerning health issue, with a significant impact on patient outcomes and healthcare systems worldwide. The emergence of antibiotic-resistant strains of bacteria limits the options for effective treatment, leading to longer and more complicated illnesses....Read more
2015 01 Mar
The FDA has approved the combination of ceftazidime-avibactam (CAZ-AVI). The antibiotic under the brand name of Avycaz will be marketed by Forest Laboratories and is indicated to treat adults with complicated intra-abdominal or urinary tract infections, including kidney infections. Ceftazidime is a third generation of cephalosporin that was approved...Read more